Sharkey, Howes & Javer’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-285
Closed -$12K 238
2017
Q4
$12K Hold
285
0.01% 145
2017
Q3
$14K Sell
285
-204
-42% -$9.87K 0.01% 141
2017
Q2
$23K Hold
489
0.01% 122
2017
Q1
$22K Hold
489
0.01% 135
2016
Q4
$20K Hold
489
0.01% 141
2016
Q3
$19K Hold
489
0.01% 137
2016
Q2
$20K Hold
489
0.01% 136
2016
Q1
$20K Sell
489
-379
-44% -$15.2K 0.01% 141
2015
Q4
$37K Hold
868
0.03% 114
2015
Q3
$44K Hold
868
0.03% 100
2015
Q2
$43K Hold
868
0.03% 86
2015
Q1
$43K Buy
+868
New +$41.5K 0.03% 102

Other funds holding SNY

Sharkey, Howes & Javer's SNY Position: Q1 2018 in Review

Sharkey, Howes & Javer sold out of Sanofi (SNY) in Q1 2018, closing a stake of 285 shares — an estimated $12K sold.

Sharkey, Howes & Javer first reported a position in SNY in Q1 2015 and held it in 12 quarters. The position peaked at $44K in Q3 2015. 487 funds tracked by Wall St. Rank hold SNY as of Q1 2018.

  • Sharkey, Howes & Javer reported no remaining Sanofi position as of Q1 2018 after selling out during the quarter.
  • Sharkey, Howes & Javer sold 285 Sanofi shares in Q1 2018, an estimated $12K.
  • Sharkey, Howes & Javer first reported a position in Sanofi in Q1 2015 and held it in 12 quarters.
  • Sharkey, Howes & Javer's Sanofi position peaked at $44K in Q3 2015.
  • 487 funds tracked by Wall St. Rank held Sanofi as of Q1 2018.

Based on Sharkey, Howes & Javer's 13F filing for Q1 2018, filed 26 Apr 2018.